Eric Ferrari - Concepedia

Author

Eric Ferrari

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

E B Ferrari, E Ferrari, E. Ferrari, Eric B. Ferrari, Eric Ferrari

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Sarepta Therapeutics (United States)

About

Eric Ferrari is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.2K
2	Natural Sciences	6	6	661
3	Biochemistry	6	6	436
4	Biomolecular Engineering	3	3	307
5	Allergy	1	1	32

Eric Ferrari

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Ming Liu, Matthew Bryant, Jianping Chen, PubMed Sch 66336Chemoprevention StrategyFarnesyl Protein TransferaseOncogenic AgentMedicine	1998	309
Characterization of Soluble Hepatitis C Virus RNA-Dependent RNA Polymerase Expressed in <i>Escherichia coli</i> Eric Ferrari, Jacquelyn Wright-Minogue, Jane Fang, Journal of Virology Viral ReplicationViral Polymerase StructureHepatitis C VirusSynthetic VirologyMolecular Biology	1999	236
De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase Weidong Zhong, Annette S. Uss, Eric Ferrari, Journal of Virology Viral ReplicationRna ReplicationViral Polymerase MechanismMolecular BiologyViral Rna Genome	2000	190
Template/Primer Requirements and Single Nucleotide Incorporation by Hepatitis C Virus Nonstructural Protein 5B Polymerase Weidong Zhong, Eric Ferrari, Charles A. Lesburg, Journal of Virology	2000	110
Mutational Analysis of Bovine Viral Diarrhea Virus RNA-Dependent RNA Polymerase Vicky C. H. Lai, C. Cheng Kao, Eric Ferrari, Journal of Virology Viral ReplicationAmino AcidsViral Polymerase StructureMolecular BiologyVirus Gene	1999	107
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system Zhi Hong, Eric Ferrari, Jacquelyn Wright-Minogue, Journal of Virology Viral ReplicationNs3 ProteaseMolecular VirologyBiochemistryHepatitis C Virus	1996	88
SCH 48973: a potent, broad-spectrum, antienterovirus compound Peter Buontempo, Stuart Cox, Jacquelyn Wright-Minogue, Antimicrobial Agents and Chemotherapy Molecular VirologyAntiviral CompoundMedicineSch 48973Antiviral Drug Development	1997	59
I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles G. Anilkumar, Charles A. Lesburg, Oleg Selyutin, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineIndole 2-Carboxylic AcidsAntiviral Drug DevelopmentAntiviral Drug	2011	49
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models. Loretta L. Nielsen, Bin Shi, Gerald Hajian, PubMed Tumor BiologyPreclinical Cancer ModelsThird DrugOncogenic AgentMedicine	1999	36
Hepatitis C Virus NS5B Polymerase Exhibits Distinct Nucleotide Requirements for Initiation and Elongation Eric Ferrari, Zhiqing He, Robert E. Palermo, Journal of Biological Chemistry	2008	35

Page 1